PHARMACEUTICAL COMPOSITION FOR TREATING GASTRO-OESOPHAGEAL REFLUX DISEASE

The invention relates to the pharmaceutical industry and provides a pharmaceutical composition for treatment of gastroesophageal reflux disease, the said composition consisting of at least one proton pump inhibitor and at least one prebiotic, while the content of the proton pump inhibitor in the com...

Full description

Saved in:
Bibliographic Details
Main Authors LAZEBNIK, LEONID BORISOVICH, BORODIN, DMITRY STANISLAVOVICH, BELOVA, ELENA VALENTINOVNA
Format Patent
LanguageEnglish
French
German
Published 04.05.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the pharmaceutical industry and provides a pharmaceutical composition for treatment of gastroesophageal reflux disease, the said composition consisting of at least one proton pump inhibitor and at least one prebiotic, while the content of the proton pump inhibitor in the composition is 0.05 to 0.25% w/w, prebiotic - 10 to 95% w/w and excipients - up to 100% w/w. The invention ensures prevention of translocation of H. pylori, eliminates the need to detect H. pylori and conduct bacteria eradication treatment, improves the security of long-term therapy with proton pump inhibitors and avoids atrophy of gastric mucosa and the risk of development of gastric cancer. 2 primary claims and 3 subordinate claims, 10 tables.
Bibliography:Application Number: EP20130832613